The European Medical Radionuclides Programme – PRISMAP – Arronax
GIP ARRONAX is part of the European medical isotope programme PRISMAP, which aims to fundamentally change the European medical radionuclide
The Scientific Advisory Board (SAB) of SIRIC ILIAD met on 16 & 17 September 2021
The International Scientific Advisory Board (SAB) met on 16 & 17 September 2021: review and improvement perspectives The role of
4th SIRIC ILIAD Scientific Day – 11 October 2021 – Nantes
The SIRIC ILIAD is organising its 4th scientific day on Monday 11 October 2021 in Nantes. The aim of
SIRIC ILIAD shares the progress of its research with its partners | Review 2020-2021
The SIRIC ILIAD Partners’ Committee met on 31 August to present its 2020-2021 results. On August 31, 2021, the fourth
SIRIC ILIAD partners with the Multimodal Imaging Centre of the Grand-Ouest: IMRAM
As a result of a partnership between Nantes University Hospital and the Western Cancer Institute (ICO), the new shared medical
SAVE THE DATE | 4th SIRIC ILIAD Scientific Day – 11 October 2021 – Nantes
The SIRIC ILIAD is organising its 4th scientific day on Monday 11 October 2021 in Nantes. The aim of this
Workshop: Adaptation of the tumour and its ecosystem to radiotherapies | September 22nd-25th, 2021 – Le Bono, West of France
The SIRIC ILIAD partner event organised by the “Tumour targeting, Imaging, radiotherapies network” of the Cancéropôle Grand-Ouest, is dedicated to
Clinical trial: 89 Zr TLX250 Immuno-PET Cohort
OPALESCENCE : 89 Zr TLX250 Immuno-PET Cohort Type of study : Single-centre study Pathology : Metastatic triple negative breast cancer
Clinical trial: EITHICS protocol
EITHICS protocol: Study of inflammation using 18F DPA714 PET Type of study: Multicentre study Pathology: Triple-negative breast cancer, operated on
Kick-off of the NOAR network, the COST project dedicated to the development of alpha therapy
On 22 October 2020 in Brussels, the COST (COoperation in Science and Technology) project dedicated to the development of alpha
